[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# Edgewise Therapeutics, Inc. Common Stock (EWTX)

Edgewise Therapeutics (EWTX) stock shows significant social media buzz with increased engagements and mentions, driven by positive Sevasemten data and analyst reiterations, despite recent price volatility.

### About Edgewise Therapeutics, Inc. Common Stock
Edgewise Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for muscle disorders.  
Edgewise Therapeutics, Inc. Common Stock uses the ticker $EWTX for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Edgewise Therapeutics, Inc. Common Stock (EWTX) market dominance near a 52-week low at XXXXXXX.
- Edgewise Therapeutics, Inc. Common Stock (EWTX) trading volume is up XXXXXX% from the previous month.
- Edgewise Therapeutics, Inc. Common Stock (EWTX) social dominance is up XXXXX% from the previous X months.
- Edgewise Therapeutics, Inc. Common Stock Price hit a 52-Week high of $XXXXX for the hour

### Price: $XXXXX
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$ewtx/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$ewtx/time-series/close.tsv)  
The stock price has recently dropped from its 1-year high, influenced by overall market sentiment and potential profit-taking, despite positive data presentations and analyst ratings. The surge in social media engagement suggests growing investor interest.  

24-Hour: -XXXX%
7-Day: -XXXX%
30-Day: XXXX%

1-Year High: $XXXXX on 2024-12-16  
1-Year Low: $XXXXX on 2025-04-12  
  
  
### AltRank: XXXXX
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$ewtx/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$ewtx/time-series/alt_rank.tsv)  
Edgewise Therapeutics, Inc. Common Stock (EWTX) is currently AltRank #1,402 based on combined combined social and market metrics
Daily Average: XXX  
X Week: XXXXX +470  
X Month: XXXXX +214  
X Months: XXXXX -XXX  
X Year: XXXXX +1,019  
1-Year High: XXXXX on 2025-09-15  
1-Year Low: XX on 2024-12-12  
  
  
### Galaxy Score: XXXXX
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$ewtx/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$ewtx/time-series/galaxy_score.tsv)  
Current Value: XXXXX  
Daily Average: XX  
X Week: XX -XX  
X Month: XX -X  
X Months: XX -XX  
X Year: XX -XX  
1-Year High: XX on 2024-12-16  
1-Year Low: XX on 2025-07-10  
  
  
### Engagements: XXXXX (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$ewtx/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$ewtx/time-series/interactions.tsv)  
Current Value: XXXXX  
Daily Average: XXXXX  
X Week: XXXXXX -XX%  
X Month: XXXXXXX +294%  
X Months: XXXXXXX -XX%  
X Year: XXXXXXXXX -X%  
1-Year High: XXXXXXX on 2024-12-16  
1-Year Low: XX on 2025-10-18  

Engagements by network (24h):
X: XXXXX

  
  
### Mentions: XX (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$ewtx/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$ewtx/time-series/posts_active.tsv)  
Current Value: XX  
Daily Average: XX  
X Week: XXX -XX%  
X Month: XXX +59%  
X Months: XXXXX -XX%  
X Year: XXXXX +13%  
1-Year High: XXX on 2024-12-17  
1-Year Low: X on 2025-10-18  

Mentions by network (24h):
X: XXX

  
  
### Creators: XX (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$ewtx/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$ewtx/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Edgewise Therapeutics, Inc. Common Stock (EWTX) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX  
X Week: XX -XX%  
X Month: XXX +30%  
X Months: XXXXX +69%  
X Year: XXXXX +78%  
1-Year High: XXX on 2025-06-28  
1-Year Low: X on 2025-10-18  

The most influential creators that mention Edgewise Therapeutics, Inc. Common Stock in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)           | X    | XX        | X     | XXX         |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ)           | X    | XXXXXX    | X     | XXX         |
| [@Quantumup1](/creator/twitter/Quantumup1)           | X    | XXXXX     | X     | XXX         |
| [@seedytx19](/creator/twitter/seedytx19)             | X    | XXXXX     | X     | XX          |
| [@StockTickerZone](/creator/twitter/StockTickerZone) | X    | XXXXX     | X     | XX          |

[View More](/list/creators/$ewtx/100)
  
  
### Sentiment: XX%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$ewtx/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$ewtx/time-series/sentiment.tsv)  
Current Value: XX%  
Daily Average: XX%  
X Week: XXX% no change  
X Month: XXX% no change  
X Months: XXX% +12%  
X Year: XXX% +25%  
1-Year High: XXX% on 2025-01-29  
1-Year Low: XX% on 2025-09-15  

Most Supportive Themes:
- Positive Sevasemten Data: (45%) Edgewise Therapeutics is presenting positive data on Sevasemten for Becker and Duchenne Muscular Dystrophies, receiving positive commentary from analysts and investors.
- Analyst Reiteration of Positive Ratings: (35%) Stifel and H.C. Wainwright have reiterated positive ratings and price targets for Edgewise Therapeutics, citing positive data and potential.
- Inclusion in Biotech Watchlists: (10%) Edgewise Therapeutics is included in biotech stock catalyst watchlists, indicating upcoming data readouts and potential catalysts.
  
Most Critical Themes:
- Stock Price Volatility: (10%) The stock price has shown volatility, with recent fluctuations and a significant drop from its 1-year high.
  
  
  
### Social Dominance: XXXXXXX%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$ewtx/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$ewtx/time-series/social_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: XXXXX%  
X Week: XXXXXX% +0.0021%  
X Month: XXXXXX% +0.0061%  
X Months: XXXXXX% -XXXXXX%  
X Year: XXXXXX% -XXXXX%  
1-Year High: XXXXX% on 2024-12-17  
1-Year Low: XXXXXX% on 2025-10-18  
  
  
### Market Dominance: XXXXXXX%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$ewtx/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$ewtx/time-series/market_dominance.tsv)  
Current Value: XXXXXXX%  
Daily Average: X%  
1-Year High: XXXXX% on 2025-03-10  
1-Year Low: XXXXXXX% on 2025-12-09  
  
  
### Market Cap: $XXXXXXXXXXXXX
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$ewtx/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$ewtx/time-series/market_cap.tsv)  
Current Value: $XXXXXXXXXXXXX  
Daily Average: $XXXXXXXXXXXXX  
X Week: $XXXXXXXXXXXXX +$7.20%  
X Month: $XXXXXXXXXXXXX +$40%  
X Months: $XXXXXXXXXXXXX +$57%  
X Year: $XXXXXXXXXXXXX -$11%  
1-Year High: $XXXXXXXXXXXXX on 2024-12-16  
1-Year Low: $XXXXXXXXXXXXX on 2025-04-11  

### Top Edgewise Therapeutics, Inc. Common Stock Social Posts
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"Highly impressed with this setup $CGEM $STOK $TVTX $CLDX $SNDX $VYGR $AMTI $EWTX $OYST $VIR $SMMT $KYMR $ADCT $HARP $INSM $IMAB $XBIT $AXSM $PASG $ZGNX $IONS $ETNB $OTLK $RYTM $RGNX $NGM $UTHR $IMVT $REGN $ADAP $NBIX $PDSB $IGMS"  
[X Link](https://x.com/BuyTheUgly/status/1998485125680738411) [@BuyTheUgly](/creator/x/BuyTheUgly) 2025-12-09T20:09Z XX followers, XXX engagements


"Did you guys fade .40 $PRSO $TBIO $ZEO $LFLY $FRGT $MAXN $TBIO $VMAR $VERI $ZEO $XCUR $GLMD $ACHL $EWTX $AMZN $GOOGL $TSLA $AMD $MSFT $NFLX $META $MSTR $NVDA $FSLR $FFIE $AAPL $QQQ $SPY $VIX $PRSO $AAPL $FSLR $MULN $BATL $BNZI $LFLY $SVMH $TNON $AENT $NVVE $NUKK $XPON $BDTX $TGL"  
[X Link](https://x.com/BuyTheUgly/status/1998136636484489603) [@BuyTheUgly](/creator/x/BuyTheUgly) 2025-12-08T21:04Z XX followers, XX engagements


"Santa rally starts here $CGEM $STOK $TVTX $CLDX $SNDX $VYGR $AMTI $EWTX $OYST $VIR $SMMT $KYMR $ADCT $HARP $INSM $IMAB $XBIT $AXSM $PASG $ZGNX $IONS $ETNB $OTLK $RYTM $RGNX $NGM $UTHR $IMVT $REGN $ADAP $NBIX $PDSB $IGMS"  
[X Link](https://x.com/BuyTheUgly/status/1998059318739194147) [@BuyTheUgly](/creator/x/BuyTheUgly) 2025-12-08T15:57Z XX followers, XXX engagements


"Raymond James $DYN's PT to $XX from $XX and reiterated at a SB $CAPR $EWTX PTCT SRPT Raymond James said: This morning Dyne announced positive topline data from the registrational expansion cohort (REC) of the Ph2 DELIVER study of z-rostudirsen (formerly DYNE-251) in Duchenne muscular dystrophy amenable to exon XX skipping (DMD51); presentation here. These results de-risk FDA accelerated approval in our view and also provide incremental de-risking for an eventual confirmatory trial. We raise our price target to $XX and reiterate our Strong Buy rating"  
[X Link](https://x.com/Quantumup1/status/1998024172946030781) [@Quantumup1](/creator/x/Quantumup1) 2025-12-08T13:37Z 3919 followers, 1956 engagements